Wegovy Side Effects: Black Tongue, Pain, Gallbladder Removal in Woman's Story

In a chilling account of Wegovy side effects, 32-year-old Sarah-Jayne Crawford from Antrim, Northern Ireland, sought semaglutide injections to shed pounds for her November 2025 wedding. What began as a promising weight loss journey ended in excruciating pain, a blackened tongue, foul egg-smelling burps, and the surgical removal of her gallbladder. Her story serves as a stark reminder of the potential risks associated with GLP-1 receptor agonists like Wegovy.

The Allure of Wegovy for Weight Loss

Wegovy, manufactured by Novo Nordisk, contains semaglutide, a GLP-1 receptor agonist that mimics hormones like GLP-1 to signal fullness to the brain, reducing appetite and promoting significant weight loss. Approved for chronic weight management in adults with obesity or overweight conditions alongside diet and exercise, it has surged in popularity due to celebrity endorsements and clinical trial results showing up to 15-20% body weight reduction over 68 weeks.

For many, including Crawford, an NHS worker weighing 19 stone 9 lbs (approximately 125 kg) and a UK size 20, Wegovy represented a 'last resort' after years of unsuccessful dieting, exercising, and starving. 'Wegovy was my last resort,' she said. 'I know a lot of people who are on the jabs and it worked like a dream for them. I had been battling my weight for what felt like forever and I was dying to slim before my wedding - but dieting, exercising and starving myself never worked.'

Sarah-Jayne Crawford's Wegovy Journey Begins

In August 2024, Crawford purchased her first month's supply of Wegovy through an online pharmacy for £199, starting at the entry-level dosage of 0.25mg. Twelve weeks later, her appetite had diminished noticeably, and she 'felt great' heading into her wedding preparations. Emboldened by early success, she invested another £350 to increase her dosage to 1mg.

These initial results aligned with Wegovy's mechanism: by slowing gastric emptying and enhancing insulin secretion, semaglutide helps control blood sugar and curbs hunger. However, rapid weight loss—often 1-2 lbs per week—can strain the body, particularly the biliary system, increasing risks for complications like gallstones.

Why GLP-1s Like Wegovy Affect the Gallbladder

GLP-1 medications promote quick fat loss, which mobilizes cholesterol from the liver into bile. This can lead to supersaturated bile, forming gallstones that block ducts. Clinical data from Wegovy's trials noted gallbladder-related events in about 1.6% of users, a risk Novo Nordisk discloses. For patients like Crawford, this statistical probability became a harsh reality.

The Onset of Severe Wegovy Side Effects

The 'honeymoon phase' ended abruptly after 12 weeks. Crawford began experiencing episodes of intense pain in her upper stomach, frequent vomiting, and an excruciating trapped-wind sensation that left her bed-bound and unable to walk. Within 24 hours, her mother noticed her tongue had turned black—a rare but alarming symptom linked to bacterial overgrowth or poor oral hygiene exacerbated by gastrointestinal distress.

Compounding the misery were foul 'egg-smelling' sulphur burps, severe mouth pain, and intolerance to spicy foods like peppers and onions. Along with her 'black tongue,' Crawford endured these symptoms, describing the pain as, 'The pain was so unbearable I couldn't walk. I would rather give birth to five kids at the same time than go through with the pain again.' 'The black tongue seemed like a cherry on top and a warning of what was to come. It all happened so quickly.'

Emergency Hospitalization and Gallbladder Surgery

Fearing the worst, Crawford stopped the jabs and rushed to the hospital. MRI and CT scans confirmed multiple gallstones blocking her bile duct, putting her at risk of pancreatitis, as reported by the Mirror. On 10 February 2025, she underwent a cholecystectomy to remove her gallbladder. Her surgeon advised her to stay off Wegovy permanently.

Recovery was gradual: her tongue regained its color, but the physical and emotional scars remain. Crawford reflected, 'But it was the complete opposite. It's not worth it. Weight loss jabs are a temporary fix and the dangers aren't obvious. I'm proof that anything can happen once you inject yourself and I have now changed my mindset.' She urged others: 'Please do your research before you commit - I can't stress enough how much women are putting themselves at risk.'

Novo Nordisk's Position on Wegovy Safety

Novo Nordisk maintains that Wegovy is safe when used as directed, emphasizing the well-documented 1.6% risk rate for gallstone disease from clinical trials. The company recommends gradual dose escalation to minimize gastrointestinal side effects and advises monitoring for symptoms like abdominal pain or jaundice. Prescribing information includes warnings for gallbladder disorders, particularly in those with rapid weight loss.

Comparing Wegovy Risks to Other GLP-1s

Semaglutide is also found in Ozempic (for diabetes) and Rybelsus (oral form), sharing similar side effect profiles. Other GLP-1s like tirzepatide (Mounjaro/Zepbound) show comparable gallbladder risks due to the class effect. Unlike statins or older weight loss drugs like phentermine, GLP-1s target hormonal pathways but demand medical supervision to mitigate dehydration, electrolyte imbalances, or biliary issues from nausea and vomiting.

Practical Guidance for Patients Considering Wegovy

Before starting Wegovy or similar GLP-1 therapies:

• Consult a healthcare provider: Discuss family history of gallstones, prior GI issues, or rapid weight loss risks.
• Start low, go slow: Follow the titration schedule (0.25mg to 2.4mg) to build tolerance.
• Monitor symptoms: Track appetite, pain, burps, or tongue changes daily. Apps like Shotlee can help log side effects, medication schedules, and symptom patterns for doctor discussions.
• Hydrate and eat fiber-rich foods: Counteract GI slowdown; avoid triggers like spicy foods if sensitive.
• Combine with lifestyle: Pair with diet and exercise for sustainable results, reducing reliance on jabs.

Common side effects include nausea (44%), diarrhea (30%), and vomiting (24%), but severe cases like Crawford's underscore the need for vigilance. If symptoms escalate, stop use and seek emergency care.

Key Takeaways: What This Means for Patients

• Wegovy's semaglutide drives effective weight loss but carries a 1.6% gallstone risk, as seen in Crawford's cholecystectomy.
• Black tongue, sulphur burps, and upper abdominal pain signal potential emergencies—do not ignore.
• Research thoroughly; online pharmacies may lack oversight.
• Weight loss jabs offer tools, not miracles—prioritize long-term health strategies.

Conclusion: Balancing Benefits and Risks of Semaglutide

Sarah-Jayne Crawford's Wegovy tragedy—from black tongue and lost organ to life-altering surgery—highlights the double-edged sword of GLP-1 weight loss injections. While millions benefit, her experience proves risks can strike anyone. Patients should weigh semaglutide's promise against documented dangers, always under medical guidance, to avoid turning a wedding dream into a health nightmare.